Intensity Modulated Radiation Therapy for Retroperitoneal Sarcoma:
A Case for Dose Escalation and Organ at Risk Toxicity Reduction

Mary  Koshy; Jerome C. Landry; Joshua D. Lawson; Charles A. Staley; Natia  Esiashvili; Rebecca  Howell; Shahram  Ghavidel; Lawrence W. Davis

doi:10.1080/13577140310001644751

Sarcoma (Jan 2003)

Intensity Modulated Radiation Therapy for Retroperitoneal Sarcoma: A Case for Dose Escalation and Organ at Risk Toxicity Reduction

Mary Koshy,
Jerome C. Landry,
Joshua D. Lawson,
Charles A. Staley,
Natia Esiashvili,
Rebecca Howell,
Shahram Ghavidel,
Lawrence W. Davis

Affiliations

Mary Koshy: Department of Radiation Oncology, Emory Clinic and Emory University, 1365 Clifton Road NE A1300, Atlanta 30322, GA, USA
Jerome C. Landry: Department of Radiation Oncology, Emory Clinic and Emory University, 1365 Clifton Road NE A1300, Atlanta 30322, GA, USA
Joshua D. Lawson: Department of Radiation Oncology, Emory Clinic and Emory University, 1365 Clifton Road NE A1300, Atlanta 30322, GA, USA
Charles A. Staley: Department of Radiation Oncology, Emory Clinic and Emory University, 1365 Clifton Road NE A1300, Atlanta 30322, GA, USA
Natia Esiashvili: Department of Radiation Oncology, Emory Clinic and Emory University, 1365 Clifton Road NE A1300, Atlanta 30322, GA, USA
Rebecca Howell: Department of Radiation Oncology, Emory Clinic and Emory University, 1365 Clifton Road NE A1300, Atlanta 30322, GA, USA
Shahram Ghavidel: Department of Radiation Oncology, Emory Clinic and Emory University, 1365 Clifton Road NE A1300, Atlanta 30322, GA, USA
Lawrence W. Davis: Department of Radiation Oncology, Emory Clinic and Emory University, 1365 Clifton Road NE A1300, Atlanta 30322, GA, USA

DOI: https://doi.org/10.1080/13577140310001644751
Journal volume & issue: Vol. 7, no. 3-4
pp. 137 – 148

Abstract

Read online

Purpose: Radiation therapy for retroperitoneal sarcoma remains challenging because of proximity to surrounding organs at risk (OAR). We report the use of intensity modulated radiation therapy (IMRT) in the treatment of retroperitoneal sarcomas to minimize dose to OAR while concurrently optimizing tumor dose coverage.

Published in Sarcoma

ISSN: 1357-714X (Print); 1369-1643 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://onlinelibrary.wiley.com/journal/5805

About the journal